I was hesitant to publish this chart because the extreme upside it shows will likely be viewed as unrealistic. However, HROW recently decisively broke above its 4-year trend channel as business developments have been quite positive lately - particularly with IHEEZO. This is a rare setup where the fundamentals and technicals both align for a sharp move to the...
Axsome Therapeutics Inc (AXSM) I have been in this spot trade since $50.77. We are now at $72.93. I have much higher targets as you can see from the chart. This is a long term trade looking to hold for 12 – 24 months however feel that something is going to happen within 6 – 12 months based on the chart. - Forming pennant on chart and RSI. Potential for...
Sunpharma broke out support trendline and retested, ready for more downsides
should be the next crispr or illumina ... it supplies stuff to MODERNA it could be the secret sauce in pre diagnotics or preventing diseases before they become serious currently winding down and allocation of shares to serious players and strong hands with conviction in the Ai Tech Cum Biologics
#SUNPHARMA... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
#APOLLOHOSP... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
MGRX a recent IPO produces a med for erectile dysfunction without FDA approval; They are basically selling a generic version of an approved medication and bypassing the patent protections and betting they will fly under the regulator radar apparatus. As might be expeted this recent nano-IPO is highlly volatile. Play with it only if you have the requisite...
WOCKPHARMA has completed a long term correction cycle and now could be a good buy with targets above 2,000 in the long term. The invalidation for this analysis remains at 135.20 (marked level).
- Big initial move right of out the gate - ~1 month consolidation - Confluence of MAs - New Momentum - High ADR - Pharma
NASDAQ:BBIO tight action. Pharma has been popping as of late - hopefully that continues. Anticipation set-up.
Tight Action on $UNCY. Massive run up on big volume and holding level.
#CIPLA... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
There is a high probability that it can hit 250 in next 3 months, it must break above 170 first. Some big news around 170 can make it hit 250.
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
48 PER broken the 14 year trend lchannel also the lower sloping 3 year ( red Channel)
Pfizer may provide a great risk to reward setup. Multi factor trade setup on pfizer likely sees a technical bounce. Keep in mind markets are weak.
going heavy at the pullback for now just a small amount to feel the progress NEURO is GOLDEN
GRANULES INDIA SHARE BUY NOW ON 288 SELL AFTER ATLEAST PROFIT OF 28 % ITS A INVESTMENT RECOS FOR INTRA RECOS wsip me 8459 22 0202 Granules India Limited is a pharmaceutical company that offers a wide range of products and services. The company has a robust business model, with a strong focus on research and development, which allows it to stay ahead of the...